Table 2.
Results of laboratory analyses at the before and the after monitoring of the study for two groups formed according to the annual percentage change in eGFR.
| Group1 Annual percentage in eGFR>-5.48%/year |
Group2 Annual percentage in eGFR≤-5.48%/year |
|||||
|---|---|---|---|---|---|---|
| Before | After | P value | Before | After | P value | |
| Annual percentage change in eGFR,%/year | 0.33(5.9) | -14.8(11.0) | ||||
| Annual percentage change in serum TBIL,%/year | 0.38(11.3) | -8.25(14.7) | ||||
| eGFR, ml/min/1.73m2 | 89.9(46.0) | 96.6(44.4) | 0.460 | 84.4(61.9) | 38.1(37.3) | <0.001 |
| BUN, mmol/L | 5.2(2.5) | 6.4(3.1) | 0.008 | 6.2(2.9) | 10.4(9.0) | <0.001 |
| Scr, µmol/L | 77.0(31.7) | 71.5(30.5) | 0.039 | 79.0(54.0) | 147.0(152.0) | <0.001 |
| ACR,A2/A3 | 24/16 | 20/20 | 0.369 | 16/47 | 7/56 | 0.038 |
| GLU, mmol/L | 10.0(5.9) | 10.2(5.7) | 0.587 | 9.2(4.3) | 7.7(4.3) | 0.031 |
| HbA1c, % | 9.2(1.5) | 8.7(3.0) | 0.798 | 9.7(3.3) | 8.2(2.5) | <0.001 |
| ALT, U/L | 19.5(19.5) | 18.5(13) | 0.231 | 17.0(12.0) | 14.0(8.2) | <0.001 |
| AST, U/L | 19.0(14.9) | 19.5(7.5) | 0.214 | 18.0(7.5) | 15.0(7.0) | <0.001 |
| GGT, U/L | 28.0(26.5) | 26.5(20.5) | 0.261 | 25.0(20.3) | 24.0(11.8) | 0.084 |
| serum TBIL, µmol/L | 12.6(7.8) | 13.8(7.0) | 0.941 | 12.2(7.6) | 8.7(4.6) | <0.001 |
| DBIL, µmol/L | 3.4(2.1) | 3.5(1.6) | 0.411 | 2.8(1.9) | 2.2(1.4) | 0.010 |
| IBIL, µmol/L | 9.7(6.5) | 9.7(6.4) | 0.752 | 9.1(6.2) | 6.4(2.9) | <0.001 |
ACR, A2:<300mg/g; A3: ≥300mg/g.